|
|
|
|
Middle aged people who sleep 5 hours or less,
may be increasing their risk of developing high
blood pressure. |
|
Dr. Tamer Fouad, M.D.
|
Wednesday 15th March, 2006
|
|
|
|
|
Persons with a genetic variation may have slower caffeine
metabolism according to a study in the March 8 issue of JAMA.
|
|
Dr. Tamer Fouad, M.D.
|
Wednesday 15th March, 2006
|
|
|
|
|
Use of amino acid supplement following a heart attack may be
harmful according to the VINTAGE MI clinical trial.
|
|
Dr. Tamer Fouad, M.D.
|
|
|
|
|
|
|
A meta-analysis indicates that use of a pulmonary artery catheter in
critically ill patients does not any add benefit.
|
|
Dr. Tamer Fouad, M.D.
|
|
|
|
|
|
|
New heart failure guidelines released by the AHA and the ACC,
stress on early diagnosis and new treatments.
|
|
Dr. Tamer Fouad, M.D.
|
Thursday 18th August, 2005
|
|
|
|
|
The ACCP released the first evidence-based guidelines for the
management of AF after cardiac surgery.
|
|
Dr. Tamer Fouad, M.D.
|
Thursday 11th August, 2005
|
|
|
|
|
A new analysis of the CADILLAC trial examined gender differences in
outcomes after treatment with angioplasty compared to stenting.
|
|
Dr. Tamer Fouad, M.D.
|
|
|
|
|
|
|
Women with diabetes have a significantly greater risk of dying from
coronary heart disease (CHD) than men with diabetes.
|
|
Dr. Tamer Fouad, M.D.
|
Monday 21st February, 2005
|
|
|
|
|
Heart patients with gastrointestinal complications should use this
combination rather than taking the anti-platelet drug Plavix.
|
|
Dr. Tamer Fouad, M.D.
|
Friday 21st January, 2005
|
|
|
|
|
The UCLA study is the first to identify a high mortality rate for advanced
heart failure patients who use insulin to manage diabetes.
|
|
Dr. Tamer Fouad, M.D.
|
Saturday 1st January, 2005
|
|
|
|
|
Celebrex more than doubled heart deaths, heart attacks, and strokes in people
enrolled in a cancer-prevention study, research shows.
|
|
Dr. Tamer Fouad, M.D.
|
|
Saturday,
18th December, 2004 |
|
|
|
|
BiDil showed a 43 percent decrease in the one-year mortality rates among
African-Americans in the study.
|
|
Dr. Tamer Fouad, M.D.
|
|
Monday, 8th November, 2004 |
|
|
|
|
Tenormin was no different to placebo in terms of death from all causes,
cardiovascular causes, or incidence of heart attack.
|
|
Dr. Tamer Fouad, M.D.
|
|
Saturday, 6th November, 2004 |
|
|
|
|
The class of drugs known as Cox-2 inhibitors is under scrutiny for increasing
the risk of heart disease and stroke.
|
|
Dr. Tamer Fouad, M.D.
|
|
Tuesday, 19th October 2004 |
|
|
|
|
New results show Altace to beneficial to people at high risk of heart attacks and stroke.
|
|
Dr. Tamer Fouad, M.D.
|
|
Thursday,
9th September 2004 |
|
|
|
|
JTV519 was tested in mice has been shown to prevent
arrhythmias. It targets leaky calcium channels. |
|
Dr. Tamer Fouad, M.D.
|
|
Monday,
3rd May 2004 |
|
|
|
|
American Heart Association outlined the first guidelines for women
to combat and prevent cardiovascular disease. |
|
Dr. Yasser Mokhtar, M.D.
|
|
Sunday, 29th February 2004 |
|
|
|
|
TEE improves diagnostic information in various cardiovascular diseases compared to conventional echo.
|
|
Dr. Yasser Mokhtar, M.D.
|
|
|
|
| Percutaneous in-situ coronary venous
arterialization is a new less invasive alternative to CABG. |
|
Dr. Yasser Mokhtar, M.D.
|
|
send
to a friend
printer
friendly version
